Alignment Healthcare (ALHC) insider files Form 144, sells 29,200 shares under 10b5-1

Rhea-AI Filing Summary

Alignment Healthcare, Inc. notice of proposed sale: a Form 144 filed reporting planned sales of Common Stock by Hyong (Ken) Kim under a Rule 10b5-1 trading plan. The filing lists two lots acquired on 03/13/2024 (35,000 shares) and 03/13/2025 (19,355 shares).

The filing also discloses recent dispositions within the prior three months: $352,356.88 for 16,506 shares sold on 01/06/2026 and $237,919.52 for 12,694 shares sold on 12/29/2025. The notice identifies a Rule 10b5-1 plan as the sale mechanism.

Insights

Insider Transactions Compliance

Form 144 reports planned sales under a Rule 10b5-1 plan by Hyong (Ken) Kim.

Hyong (Ken) Kim is listed as the reporting person and the filing cites a Rule 10b5-1 trading plan as the method for at least some sales. The excerpt lists two grant/vesting origins: 03/13/2024 (35,000 shares) and 03/13/2025 (19,355 shares).

Recent dispositions in the past three months are shown with exact proceeds: $352,356.88 for 16,506 shares on 01/06/2026 and $237,919.52 for 12,694 shares on 12/29/2025. Filings of this type are notice of intended sales and include explicit transaction-method language; cash-flow treatment is as reported in the sales rows.

Equity Markets / Dilution Context

Disposals shown are routine insider liquidity events, disclosed with specific share counts and dollar proceeds.

The filing shows previously vested restricted stock units being the source of the shares (two discrete vesting dates and quantities). The two recent sales total 29,200 shares and combined proceeds of $590,276.40 as reported in the excerpt.

These items provide transparent transaction scale; their investor impact depends on total outstanding shares not provided in this excerpt. Subsequent filings may include additional context about remaining holdings.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	38762	658558.84	204296493	03/18/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/13/2024	The Common Stock was acquired through the vesting of restricted stock units granted on 03/13/2024 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			35000	03/13/2024	n/a
Common Stock	03/13/2025	The Common Stock was acquired through the vesting of restricted stock units granted on 03/13/2025 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			19355	03/13/2025	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Hyong (Ken) Kim Rule 10b5-1 Trading Plan 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	01/06/2026	16506	352356.88
Hyong (Ken) Kim 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	12/29/2025	12694	237919.52

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Alignment Healthcare's (ALHC) Form 144 disclose?

The Form 144 notifies planned sales of Common Stock by Hyong (Ken) Kim under a Rule 10b5-1 plan. It lists vested shares from 03/13/2024 (35,000) and 03/13/2025 (19,355) and recent sales of 16,506 and 12,694 shares.

How many shares were sold in the past three months per the filing?

The excerpt reports two dispositions: 16,506 shares sold on 01/06/2026 and 12,694 shares sold on 12/29/2025

What proceeds did the recent insider sales generate?

The disclosed proceeds are $352,356.88 for the 16,506-share sale on 01/06/2026 and $237,919.52 for the 12,694-share sale on 12/29/2025

Were the shares originated from equity compensation?

Yes. The filing states the shares were acquired through the vesting of restricted stock units under the Issuer's 2021 Equity Incentive Plan, with vesting dates 03/13/2024 (35,000) and 03/13/2025 (19,355).

Does the Form 144 state how the sales will be executed?

The excerpt identifies a Rule 10b5-1 trading plan for the reported sales. Specific execution methods or broker details beyond the plan reference are provided in the sale rows but broader distribution mechanics are not expanded upon in this excerpt.